chr17-5022186-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006612.6(KIF1C):​c.2105C>T​(p.Thr702Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00752 in 1,614,108 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0049 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0078 ( 60 hom. )

Consequence

KIF1C
NM_006612.6 missense

Scores

6
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.603

Publications

8 publications found
Variant links:
Genes affected
KIF1C (HGNC:6317): (kinesin family member 1C) The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]
KIF1C-AS1 (HGNC:40324): (KIF1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0073581636).
BP6
Variant 17-5022186-C-T is Benign according to our data. Variant chr17-5022186-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 390510.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00492 (750/152368) while in subpopulation NFE AF = 0.00923 (628/68036). AF 95% confidence interval is 0.00863. There are 2 homozygotes in GnomAd4. There are 296 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1CNM_006612.6 linkc.2105C>T p.Thr702Ile missense_variant Exon 22 of 23 ENST00000320785.10 NP_006603.2 O43896
KIF1CXM_005256424.3 linkc.2105C>T p.Thr702Ile missense_variant Exon 23 of 24 XP_005256481.1 O43896

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1CENST00000320785.10 linkc.2105C>T p.Thr702Ile missense_variant Exon 22 of 23 1 NM_006612.6 ENSP00000320821.5 O43896
KIF1CENST00000573815.1 linkn.647C>T non_coding_transcript_exon_variant Exon 6 of 6 5
KIF1C-AS1ENST00000438266.2 linkn.172-1231G>A intron_variant Intron 1 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.00493
AC:
750
AN:
152250
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00166
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00216
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00923
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00473
AC:
1184
AN:
250276
AF XY:
0.00465
show subpopulations
Gnomad AFR exome
AF:
0.00163
Gnomad AMR exome
AF:
0.000752
Gnomad ASJ exome
AF:
0.00279
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00315
Gnomad NFE exome
AF:
0.00862
Gnomad OTH exome
AF:
0.00540
GnomAD4 exome
AF:
0.00779
AC:
11384
AN:
1461740
Hom.:
60
Cov.:
32
AF XY:
0.00765
AC XY:
5565
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33480
American (AMR)
AF:
0.000760
AC:
34
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00352
AC:
92
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000939
AC:
81
AN:
86258
European-Finnish (FIN)
AF:
0.00467
AC:
249
AN:
53316
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
0.00944
AC:
10494
AN:
1111972
Other (OTH)
AF:
0.00662
AC:
400
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
718
1435
2153
2870
3588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00492
AC:
750
AN:
152368
Hom.:
2
Cov.:
32
AF XY:
0.00397
AC XY:
296
AN XY:
74518
show subpopulations
African (AFR)
AF:
0.00166
AC:
69
AN:
41598
American (AMR)
AF:
0.000588
AC:
9
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00216
AC:
23
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00923
AC:
628
AN:
68036
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
38
75
113
150
188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00770
Hom.:
7
Bravo
AF:
0.00450
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00960
AC:
37
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00907
AC:
78
ExAC
AF:
0.00469
AC:
569
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00731
EpiControl
AF:
0.00688

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIF1C: BS2 -

Nov 01, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Spastic ataxia 2 Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Nov 15, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.029
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.0074
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.2
L
PhyloP100
0.60
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.13
Sift
Uncertain
0.0080
D
Sift4G
Benign
0.13
T
Polyphen
0.84
P
Vest4
0.37
MVP
0.78
MPC
1.0
ClinPred
0.0092
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.068
gMVP
0.47
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138935423; hg19: chr17-4925481; API